Radcliffe Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 45 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$13,943
-50.0%
200,0490.0%0.00%0.0%
Q2 2023$27,877
+63.9%
200,0490.0%0.00%
+100.0%
Q1 2023$17,004
-99.2%
200,0490.0%0.00%
-98.5%
Q4 2022$2,052,503
+2.3%
200,0490.0%0.06%
+35.4%
Q3 2022$2,007,000
+0.2%
200,0490.0%0.05%
+4.3%
Q2 2022$2,003,000
+1.4%
200,0490.0%0.05%
+2.2%
Q1 2022$1,976,000200,0490.04%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$1,976,0000.04%
Q Global Advisors, LLC 195,694$45,0000.03%
Telemetry Investments, L.L.C. 33,303$7,0000.01%
FIFTH LANE CAPITAL, LP 51,250$12,0000.01%
MARSHALL WACE, LLP 190,150$1,879,0000.00%
CANTOR FITZGERALD, L. P. 250,000$58,0000.00%
MMCAP International Inc. SPC 325,000$75,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 650,866$150,0000.00%
Context Capital Management, LLC 105,069$24,0000.00%
COWEN AND COMPANY, LLC 94,785$22,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders